Deciphera is seeking an experienced and highly motivated Territory Manager with a passion for building customer partnerships and preparing for the anticipated launch of tirabrutinib, a highly potent and selective Bruton tyrosine kinase (BTK) inhibitor being advanced for patients with relapsed or refractory primary central nervous system lymphoma (R/R PCNSL). PCNSL is a rare and aggressive extra-nodal non-Hodgkin lymphoma with significant unmet need, and tirabrutinib represents an important potential new treatment option for patients facing limited therapeutic choices. The Territory Manager will be responsible for developing and executing a territory business plan, building strong relationships with key customers and treatment centers, and partnering closely with cross-functional stakeholders to support launch readiness and help bring tirabrutinib to patients in need. This role requires the ability to provide disease education on PCNSL, communicate the clinical profile of tirabrutinib, describe pivotal data in a clear and compelling manner, and address both clinical and non-clinical barriers that may impact treatment adoption and patient access. The Territory Manager will also be expected to bring forward market insights, adapt quickly to changing launch dynamics, and contribute to a seamless experience for providers and patients within the assigned geography.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior